Annual ROE:
23.26%-0.29%(-1.23%)Summary
- As of today, AMPH annual return on equity is 23.26%, with the most recent change of -0.29% (-1.23%) on December 31, 2024.
- During the last 3 years, AMPH annual ROE has risen by +9.10% (+64.27%).
- AMPH annual ROE is now -1.23% below its all-time high of 23.55%, reached on December 31, 2023.
Performance
AMPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
14.90%-3.39%(-18.53%)Summary
- As of today, AMPH quarterly return on equity is 14.90%, with the most recent change of -3.39% (-18.53%) on September 30, 2025.
- Over the past year, AMPH quarterly ROE has dropped by -8.66% (-36.76%).
- AMPH quarterly ROE is now -42.56% below its all-time high of 25.94%, reached on June 30, 2024.
Performance
AMPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AMPH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -1.2% | -36.8% |
| 3Y3 Years | +64.3% | -9.0% |
| 5Y5 Years | +98.0% | +751.4% |
AMPH ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -1.2% | +64.3% | -42.6% | at low |
| 5Y | 5-Year | -1.2% | +9204.0% | -42.6% | +5860.0% |
| All-Time | All-Time | -1.2% | +680.0% | -42.6% | +377.5% |
AMPH ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | 14.90%(-18.5%) |
| Jun 2025 | - | 18.29%(-7.1%) |
| Mar 2025 | - | 19.69%(-14.0%) |
| Dec 2024 | 23.26%(-1.2%) | 22.89%(-2.8%) |
| Sep 2024 | - | 23.56%(-9.2%) |
| Jun 2024 | - | 25.94%(+2.1%) |
| Mar 2024 | - | 25.40%(+7.1%) |
| Dec 2023 | 23.55%(+25.5%) | 23.71%(-3.0%) |
| Sep 2023 | - | 24.45%(+28.1%) |
| Jun 2023 | - | 19.08%(+4.9%) |
| Mar 2023 | - | 18.19%(-2.2%) |
| Dec 2022 | 18.76%(+32.5%) | 18.59%(+13.6%) |
| Sep 2022 | - | 16.37%(-17.7%) |
| Jun 2022 | - | 19.88%(+8.1%) |
| Mar 2022 | - | 18.39%(+30.3%) |
| Dec 2021 | 14.16%(+5564.0%) | 14.11%(+68.0%) |
| Sep 2021 | - | 8.40%(+228.1%) |
| Jun 2021 | - | 2.56%(+631.4%) |
| Mar 2021 | - | 0.35%(+40.0%) |
| Dec 2020 | 0.25%(-97.9%) | 0.25%(-85.7%) |
| Sep 2020 | - | 1.75%(+96.6%) |
| Jun 2020 | - | 0.89%(-92.8%) |
| Mar 2020 | - | 12.44%(+9.0%) |
| Dec 2019 | 11.75% | 11.41%(-6.2%) |
| Sep 2019 | - | 12.16%(-7.0%) |
| Jun 2019 | - | 13.08%(+2825.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -0.48%(+75.6%) |
| Dec 2018 | -1.91%(-273.6%) | -1.97%(+14.3%) |
| Sep 2018 | - | -2.30%(+16.1%) |
| Jun 2018 | - | -2.74%(-115.7%) |
| Mar 2018 | - | -1.27%(-209.5%) |
| Dec 2017 | 1.10%(-67.4%) | 1.16%(+1188.9%) |
| Sep 2017 | - | 0.09%(-92.7%) |
| Jun 2017 | - | 1.24%(-55.9%) |
| Mar 2017 | - | 2.81%(-16.9%) |
| Dec 2016 | 3.37%(+447.4%) | 3.38%(-50.9%) |
| Sep 2016 | - | 6.88%(+45.1%) |
| Jun 2016 | - | 4.74%(+3546.2%) |
| Mar 2016 | - | 0.13%(+113.3%) |
| Dec 2015 | -0.97%(+75.8%) | -0.98%(+78.4%) |
| Sep 2015 | - | -4.54%(+15.5%) |
| Jun 2015 | - | -5.37%(-52.6%) |
| Mar 2015 | - | -3.52%(+10.9%) |
| Dec 2014 | -4.01%(-182.0%) | -3.95%(-64.6%) |
| Sep 2014 | - | -2.40%(-458.1%) |
| Jun 2014 | - | -0.43%(-113.7%) |
| Mar 2014 | - | 3.14%(-35.3%) |
| Dec 2013 | 4.89%(-68.5%) | 4.85%(-18.8%) |
| Sep 2013 | - | 5.97%(-21.9%) |
| Jun 2013 | - | 7.64%(+19.4%) |
| Mar 2013 | - | 6.40%(-17.4%) |
| Dec 2012 | 15.50% | - |
| Dec 2012 | - | 7.75% |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual return on equity?
- What is the all-time high annual ROE for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of AMPH is 23.26%
What is the all-time high annual ROE for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual return on equity is 23.55%
What is Amphastar Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, AMPH annual return on equity has changed by -0.29% (-1.23%)
What is Amphastar Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of AMPH is 14.90%
What is the all-time high quarterly ROE for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly return on equity is 25.94%
What is Amphastar Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, AMPH quarterly return on equity has changed by -8.66% (-36.76%)